|
生物種
|
リソース名
|
RRC ID
|
タイトル
|
ジャーナル
|
公開日
|
外部リンク
|
|
遺伝子材料
|
CSII-CMV-MCS-IRES2-Venus (RDB04383)
|
86617
|
c-FOS Confers Stem Cell-like Features to Multiple Myeloma Cells in a Bone Marrow Microenvironment.
|
Cells |
2025-3-21 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
WiDr-TC(RCB1908)
,
COLO205(RCB2127)
|
86033
|
Protein phosphatase 6 promotes stemness of colorectal cancer cells.
|
Cancer Sci |
2024-9-1 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
ACC-MESO-4(RCB2293)
,
293T(RCB2202)
|
86023
|
SLC13A5 plays an essential role in the energy shift to oxidative phosphorylation in cisplatin-resistant mesothelioma stem cells.
|
Pathol Int |
2025-3-1 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
CACO-2(RCB0988)
,
KP4(RCB1005)
|
85905
|
AMIGO2 accelerates tumor progression by inducing a cancer stem cell-like phenotype.
|
Sci Rep |
2025-9-25 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
MCF7(RCB1904)
,
SK-BR-3(RCB2132)
|
85774
|
Silencing of fibronectin type III domain-containing protein 3A (FNDC3A) attenuates epithelial-to-mesenchymal transition (EMT), cancer invasion, and stemness in triple-negative breast cancer (TNBC).
|
Biochim Biophys Acta Mol Cell Res |
2025-4-1 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
293T(RCB2202)
,
MG-63(RCB1890)
|
85392
|
PDK1-dependent metabolic reprogramming regulates stemness and tumorigenicity of osteosarcoma stem cells through ATF3.
|
Cell Death Dis |
2025-7-29 |
Pubmed
Full text
|
|
遺伝子材料
|
pTcf7wtluc (RDB02968)
|
85104
|
Basroparib overcomes acquired resistance to MEK inhibitors by inhibiting Wnt-mediated cancer stemness in KRAS-mutated colorectal cancer.
|
Biochem Pharmacol |
2025-5-1 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
DAUDI(RCB1640)
|
84384
|
EVA1-antibody drug conjugate is a new therapeutic strategy for eliminating glioblastoma-initiating cells.
|
Neuro Oncol |
2025-3-7 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
MKN1(RCB1003)
,
MKN7
,
MKN28(RCB1000)
,
MKN45(RCB1001)
|
83065
|
FOXP4 Is a Direct YAP1 Target That Promotes Gastric Cancer Stemness and Drives Metastasis.
|
Cancer Res |
2024-11-4 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
MG-63(RCB1890)
|
82698
|
SPRR1A is a potential therapeutic target for osteosarcoma: in vitro and in vivo evaluations using generated artificial osteosarcoma cancer stem cell‑like cells.
|
Oncol Rep |
2025-2-1 |
Pubmed
Full text
|